-
A Peek Into The Market Before The Trading Starts
Thursday, February 3, 2011 - 8:49am | 456Pre-open movers US stock futures are mixed this morning, as investors are awaiting jobless-claims data and earnings report. Futures on the Dow Jones Industrial Average rose 7 points to 11,992 and S&P 500 futures fell 1.80 points to 1,298.20. Nasdaq 100 futures fell 1.75 points to 2,318. A Peek...
-
Merck Reports Q4 EPS of $0.88
Thursday, February 3, 2011 - 8:05am | 56Merck & Co Inc (NYSE: MRK) reports its Q4 EPS at $0.88, beating the consensus of $0.83. MRK reports its Q4 revenue at $12.09 billion, versus the consensus of $11.52 billion. MRK shares gained 0.03% to $33.83 in after-hours trading. Read more from Benzinga's Company news.
-
US Stock Futures Mixed As Investors Await Earnings Reports, Economic Data; Merck Earnings In Focus
Thursday, February 3, 2011 - 7:45am | 438US stock futures are mixed this morning, as investors are awaiting jobless-claims data and earnings report from Merck & Co (NYSE: MRK). Futures on the Dow Jones Industrial Average rose 7 points to 11,992 and S&P 500 futures fell 0.40 point to 1,299.60. Nasdaq 100 futures fell 3.50 to 2,316....
-
Earnings Scheduled For February 3 (K, MA, CI, ITT, SUN, CAH, MRK, NYT, DOW, BX, LVS, DO, CSTR, CME, IP, GR, MCO, HOT)
Thursday, February 3, 2011 - 4:28am | 465Kellogg Company (NYSE: K) is expected to report its Q4 earnings at $0.51 per share on revenue of $2.85 billion. MasterCard (NYSE: MA) is projected to report its Q4 EPS at $3.04 on revenue of $1.42 billion. Cigna (NYSE: CI) is projected to report its Q4 EPS at $1.02 on revenue of $5.36 billion. ITT...
-
Stocks Going Ex Dividend the Second Week of February
Thursday, February 3, 2011 - 12:49am | 733Here is our latest update on the stock trading technique called 'Buying Dividends'. This is the process of buying stocks before the ex dividend date and selling the stock shortly after the ex date at about the same price, yet still being entitled to the dividend. This technique generally works only...
-
Allergan Posts Earnings Increase - Analyst Blog
Wednesday, February 2, 2011 - 4:01pm | 853Allergan, Inc. (AGN) reported fourth quarter earnings of 88 cents per share, a penny short of the Zacks Consensus Estimate but towards the higher end of its guidance range. While earnings increased 12.8% from the year-ago quarter, revenues increased 6.9% to $1,309.3 million. Revenues easily...
-
Allergan Posts Earnings Increase - Analyst Blog
Wednesday, February 2, 2011 - 3:30pm | 853Allergan, Inc. (AGN) reported fourth quarter earnings of 88 cents per share, a penny short of the Zacks Consensus Estimate but towards the higher end of its guidance range. While earnings increased 12.8% from the year-ago quarter, revenues increased 6.9% to $1,309.3 million. Revenues easily...
-
Hospira Misses; 2011 View Weak - Analyst Blog
Wednesday, February 2, 2011 - 2:31pm | 806Hospira Inc.(HSP) reported earnings per share of 77 cents for the fourth quarter of 2010, much below the Zacks Consensus Estimate of 93 cents and the year-earlier earnings of 87 cents. The lackluster earnings performance was due to lower revenues and higher research and development expenses....
-
Hospira Misses; 2011 View Weak - Analyst Blog
Wednesday, February 2, 2011 - 2:15pm | 806Hospira Inc.(HSP) reported earnings per share of 77 cents for the fourth quarter of 2010, much below the Zacks Consensus Estimate of 93 cents and the year-earlier earnings of 87 cents. The lackluster earnings performance was due to lower revenues and higher research and development expenses....
-
Covidien Outshines, Backs View - Analyst Blog
Wednesday, February 2, 2011 - 1:31pm | 1217International medical technology giant Covidien plc (COV) reported first-quarter fiscal 2011 (ended December 24) adjusted earnings per share (from continuing operation) of 95 cents, outstripping the Zacks Consensus Estimate of 81 cents and exceeding the year-ago earnings of 84 cents. Adjusted...
-
Covidien Outshines, Backs View - Analyst Blog
Wednesday, February 2, 2011 - 1:00pm | 1217International medical technology giant Covidien plc (COV) reported first-quarter fiscal 2011 (ended December 24) adjusted earnings per share (from continuing operation) of 95 cents, outstripping the Zacks Consensus Estimate of 81 cents and exceeding the year-ago earnings of 84 cents. Adjusted...
-
HITK Enters Oversold Territory - Tale of the Tape
Wednesday, February 2, 2011 - 12:10pm | 112Hi-Tech Pharmacal Co.'s (HITK) share price has entered into oversold territory with a stochastic value of 19.73. The Zacks Consensus Estimate on the company's earnings for April 2011 increased by 32 cents over the past two months to $2.69 per share. Hi-Tech Pharmacal Co. is a Zacks #1 Rank (“Strong...
-
HITK Enters Oversold Territory - Tale of the Tape
Wednesday, February 2, 2011 - 11:47am | 112Hi-Tech Pharmacal Co.'s (HITK) share price has entered into oversold territory with a stochastic value of 19.73. The Zacks Consensus Estimate on the company's earnings for April 2011 increased by 32 cents over the past two months to $2.69 per share. Hi-Tech Pharmacal Co. is a Zacks #1 Rank (“Strong...
-
AstraZeneca and HealthCore Announce Real-World Evidence Data Collaboration
Wednesday, February 2, 2011 - 11:33am | 116AstraZeneca Pharmaceuticals LP (NYSE: AZN) and HealthCore, Inc., the health outcomes research subsidiary of WellPoint, Inc. (NYSE: WLP), today announced a collaborative agreement to conduct real-world studies designed to determine how to most effectively and economically treat disease. The...
-
Stock Market News for Feb 02, 2011 - Market News
Wednesday, February 2, 2011 - 10:52am | 1424Markets rose to fresh new highs as positive economic data and strong earnings results from energy stocks led the rally. The Dow closed above the 12,000 mark for the first time since June 2008 thanks to strong gains by Exxon Mobil (NYSE:XOM), Alcoa (NYSE:AA) and Pfizer (NYSE:PFE). The blue-chip...